Detalhe da pesquisa
1.
Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin α4ß1.
Biochem Biophys Res Commun
; 400(4): 619-24, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20807504
2.
Discovery, modeling, and human pharmacokinetics of N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide (TBC3711), a second generation, ETA selective, and orally bioavailable endothelin antagonist.
J Med Chem
; 47(8): 1969-86, 2004 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-15055997
3.
Nonpeptide endothelin antagonists in clinical development.
Drugs Today (Barc)
; 37(7): 441-453, 2001 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12750762